.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

In-person and virtual events just for HCPs

SpecialtySee All >

Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer

Advertise
About OncLive
Editorial Board
MJH Life Sciences brands
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information

2 Clarke Drive
Suite 100
Cranbury, NJ 08512

Personalizing Therapy for Advanced Prostate Cancer

EP. 1: Heritable Prostate Cancer: Germline vs Somatic Mutations

June 26th 2017

EP. 2: Genetic Testing in Prostate Cancer

June 26th 2017

EP. 3: Molecular Testing in Prostate Cancer

June 26th 2017

EP. 4: Active Surveillance in Prostate Cancer

June 26th 2017

EP. 5: Combination Therapies in Localized Prostate Cancer

June 26th 2017

EP. 6: Abiraterone and Chemotherapy in CRPC

June 26th 2017

EP. 7: Radiation Therapy and ADT in CRPC

June 26th 2017

EP. 8: Sequencing and Layering of Drugs in CRPC

June 26th 2017

EP. 9: AR-V7 Testing in mCRPC

June 26th 2017

EP. 10: Future of PARP Inhibitors in mCRPC

June 26th 2017

EP. 11: Radium-223 in mCRPC

June 26th 2017

EP. 12: Radium-223 in Combination Therapy for mCRPC

June 26th 2017

EP. 13: Future Directions in Treating Advanced Prostate Cancer

June 26th 2017